Novo Nordisk Hit With UK Industry Association Suspension Over Weight Loss Drug Promotion
Further Audits Will Investigate Company Practices
Novo Nordisk has been hit by a serious sanction in the UK after having been found to effectively pay pharmacists to promote Saxenda.
